发明名称 HETEROCYCLIC SULFIDE
摘要 PURPOSE: To obtain a medicine for immune stimulation, immune resurrection and cytostatic treatment, comprising a specific heterocyclic sulfide. CONSTITUTION: This medicine comprises a compound of formula I [Het is a five-membered or six-membered heterocyclic ring which may be substituted; R<1> is an alkyl, an alkenyl or a cycloalkyl in which O, S or an NR' (R' is a 1-4C alkyl) can be present in the chain or which may be substituted or a cycloalkyl which may be optionally substituted], with the proviso that a compound of formula II ((n) is 1-5) is omitted, such as 2 methylmercapto-4-methyl-1,3- thiazol-5-ylacetic acid as an active ingredient. The compound has an LD50 value larger than 1,000mg/kg in intravenous injection of mouse, 0.5-100mg/weight Kg and cytostatic amount effective for warm-blooded mammal by parenteral and oral administration and shows no toxicity in the administration.
申请公布号 JPS6452719(A) 申请公布日期 1989.02.28
申请号 JP19880184752 申请日期 1988.07.26
申请人 HOECHST AG 发明人 KAARUUHAINTSU SHIYOINEMAN;BUARUTAA DEYURUKUHAIMAA;YURUGEN BURUMUBATSUHA;MIHIAERU RIMUBERUTO;HANSUUURURITSUHI SHIYORUREMAA;GEERUHARUTO DEIKUNAITE;HANSUUHAARARUTO ZETORATSUEKU
分类号 A61K31/33;A61K31/41;A61K31/415;A61K31/4184;A61K31/425;A61K31/426;A61K31/428;A61K31/433;A61K31/455;A61K31/465;A61K31/53;A61P31/04;A61P35/00;A61P37/00;A61P37/04;A61P43/00;C07D211/54;C07D211/84;C07D213/80;C07D231/18;C07D235/28;C07D237/18;C07D239/38;C07D241/18;C07D249/12;C07D253/06;C07D253/07;C07D277/20;C07D277/32;C07D277/36;C07D277/46;C07D277/56;C07D277/70;C07D277/74;C07D285/12;C07D285/125;C07D521/00 主分类号 A61K31/33
代理机构 代理人
主权项
地址